← All organizations

MELISA Institute Genomics & Proteomics Research SpA

Academic/Hospital

Also known as: MELISA Institute Genomics & Proteomics Research SpA

Highest phase reached

Phase 3

First clinical trial

Sep 30, 2020

Last known activity

Sep 30, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

Recent trials (3)

  • NCT04446065Reponsible party - principal investigatorPhase 2/Phase 3Sep 30, 2020
  • NCT04446065Study directorPhase 2/Phase 3Sep 30, 2020
  • NCT04446065Lead sponsorPhase 2/Phase 3Sep 30, 2020

Details

Last known activity
Sep 30, 2020